Cargando…
Impaired T-cell response to phytohemagglutinin (PHA) in tuberculosis patients is associated with high IL-6 plasma levels and normalizes early during anti-mycobacterial treatment
PURPOSE: Human tuberculosis is characterized by immunopathology that affects T-cell phenotype and functions. Previous studies found impaired T-cell response to phytohemagglutinin (PHA) in patients with acute tuberculosis. However, the influence of disease severity, affected T-cell subsets, and under...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352402/ https://www.ncbi.nlm.nih.gov/pubmed/36650358 http://dx.doi.org/10.1007/s15010-023-01977-1 |
_version_ | 1785074506520330240 |
---|---|
author | Vivekanandan, Monika M. Adankwah, Ernest Aniagyei, Wilfred Acheampong, Isaac Minadzi, Difery Yeboah, Augustine Arthur, Joseph F. Lamptey, Millicent Abass, Mohammed K. Kumbel, Francis Osei-Yeboah, Francis Gawusu, Amidu Debrah, Linda Batsa Owusu, Dorcas O. Debrah, Alexander Mayatepek, Ertan Seyfarth, Julia Phillips, Richard O. Jacobsen, Marc |
author_facet | Vivekanandan, Monika M. Adankwah, Ernest Aniagyei, Wilfred Acheampong, Isaac Minadzi, Difery Yeboah, Augustine Arthur, Joseph F. Lamptey, Millicent Abass, Mohammed K. Kumbel, Francis Osei-Yeboah, Francis Gawusu, Amidu Debrah, Linda Batsa Owusu, Dorcas O. Debrah, Alexander Mayatepek, Ertan Seyfarth, Julia Phillips, Richard O. Jacobsen, Marc |
author_sort | Vivekanandan, Monika M. |
collection | PubMed |
description | PURPOSE: Human tuberculosis is characterized by immunopathology that affects T-cell phenotype and functions. Previous studies found impaired T-cell response to phytohemagglutinin (PHA) in patients with acute tuberculosis. However, the influence of disease severity, affected T-cell subsets, and underlying mechanisms remain elusive. METHODS: Here we investigated PHA-induced and antigen-specific T-cell effector cytokines in tuberculosis patients (n = 55) as well as in healthy asymptomatic contacts (n = 32) from Ghana. Effects of Mycobacterium (M.) tuberculosis sputum burden and treatment response were analyzed and compared during follow-up. Finally, cytokine characteristics of the aberrant plasma milieu in tuberculosis were analyzed as a potential cause for impaired PHA response. RESULTS: PHA-induced IFN-γ expression was significantly lower in sputum-positive tuberculosis patients as compared to both, contacts and paucibacillary cases, and efficiently discriminated the study groups. T-cell responses to PHA increased significantly early during treatment and this was more pronounced in tuberculosis patients with rapid treatment response. Analysis of alternative cytokines revealed distinct patterns and IL-22, as well as IL-10, showed comparable expression to IFN-γ in response to PHA. Finally, we found that high IL-6 plasma levels were strongly associated with impaired IFN-γ and IL-22 response to PHA. CONCLUSION: We conclude that impaired T-cell response to PHA stimulation in acute tuberculosis patients (i) was potentially caused by the aberrant plasma milieu, (ii) affected differentially polarized T-cell subsets, (iii) normalized early during treatment. This study shed light on the mechanisms of impaired T-cell functions in tuberculosis and yielded promising biomarker candidates for diagnosis and monitoring of treatment response. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s15010-023-01977-1. |
format | Online Article Text |
id | pubmed-10352402 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-103524022023-07-19 Impaired T-cell response to phytohemagglutinin (PHA) in tuberculosis patients is associated with high IL-6 plasma levels and normalizes early during anti-mycobacterial treatment Vivekanandan, Monika M. Adankwah, Ernest Aniagyei, Wilfred Acheampong, Isaac Minadzi, Difery Yeboah, Augustine Arthur, Joseph F. Lamptey, Millicent Abass, Mohammed K. Kumbel, Francis Osei-Yeboah, Francis Gawusu, Amidu Debrah, Linda Batsa Owusu, Dorcas O. Debrah, Alexander Mayatepek, Ertan Seyfarth, Julia Phillips, Richard O. Jacobsen, Marc Infection Research PURPOSE: Human tuberculosis is characterized by immunopathology that affects T-cell phenotype and functions. Previous studies found impaired T-cell response to phytohemagglutinin (PHA) in patients with acute tuberculosis. However, the influence of disease severity, affected T-cell subsets, and underlying mechanisms remain elusive. METHODS: Here we investigated PHA-induced and antigen-specific T-cell effector cytokines in tuberculosis patients (n = 55) as well as in healthy asymptomatic contacts (n = 32) from Ghana. Effects of Mycobacterium (M.) tuberculosis sputum burden and treatment response were analyzed and compared during follow-up. Finally, cytokine characteristics of the aberrant plasma milieu in tuberculosis were analyzed as a potential cause for impaired PHA response. RESULTS: PHA-induced IFN-γ expression was significantly lower in sputum-positive tuberculosis patients as compared to both, contacts and paucibacillary cases, and efficiently discriminated the study groups. T-cell responses to PHA increased significantly early during treatment and this was more pronounced in tuberculosis patients with rapid treatment response. Analysis of alternative cytokines revealed distinct patterns and IL-22, as well as IL-10, showed comparable expression to IFN-γ in response to PHA. Finally, we found that high IL-6 plasma levels were strongly associated with impaired IFN-γ and IL-22 response to PHA. CONCLUSION: We conclude that impaired T-cell response to PHA stimulation in acute tuberculosis patients (i) was potentially caused by the aberrant plasma milieu, (ii) affected differentially polarized T-cell subsets, (iii) normalized early during treatment. This study shed light on the mechanisms of impaired T-cell functions in tuberculosis and yielded promising biomarker candidates for diagnosis and monitoring of treatment response. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s15010-023-01977-1. Springer Berlin Heidelberg 2023-01-18 2023 /pmc/articles/PMC10352402/ /pubmed/36650358 http://dx.doi.org/10.1007/s15010-023-01977-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Vivekanandan, Monika M. Adankwah, Ernest Aniagyei, Wilfred Acheampong, Isaac Minadzi, Difery Yeboah, Augustine Arthur, Joseph F. Lamptey, Millicent Abass, Mohammed K. Kumbel, Francis Osei-Yeboah, Francis Gawusu, Amidu Debrah, Linda Batsa Owusu, Dorcas O. Debrah, Alexander Mayatepek, Ertan Seyfarth, Julia Phillips, Richard O. Jacobsen, Marc Impaired T-cell response to phytohemagglutinin (PHA) in tuberculosis patients is associated with high IL-6 plasma levels and normalizes early during anti-mycobacterial treatment |
title | Impaired T-cell response to phytohemagglutinin (PHA) in tuberculosis patients is associated with high IL-6 plasma levels and normalizes early during anti-mycobacterial treatment |
title_full | Impaired T-cell response to phytohemagglutinin (PHA) in tuberculosis patients is associated with high IL-6 plasma levels and normalizes early during anti-mycobacterial treatment |
title_fullStr | Impaired T-cell response to phytohemagglutinin (PHA) in tuberculosis patients is associated with high IL-6 plasma levels and normalizes early during anti-mycobacterial treatment |
title_full_unstemmed | Impaired T-cell response to phytohemagglutinin (PHA) in tuberculosis patients is associated with high IL-6 plasma levels and normalizes early during anti-mycobacterial treatment |
title_short | Impaired T-cell response to phytohemagglutinin (PHA) in tuberculosis patients is associated with high IL-6 plasma levels and normalizes early during anti-mycobacterial treatment |
title_sort | impaired t-cell response to phytohemagglutinin (pha) in tuberculosis patients is associated with high il-6 plasma levels and normalizes early during anti-mycobacterial treatment |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352402/ https://www.ncbi.nlm.nih.gov/pubmed/36650358 http://dx.doi.org/10.1007/s15010-023-01977-1 |
work_keys_str_mv | AT vivekanandanmonikam impairedtcellresponsetophytohemagglutininphaintuberculosispatientsisassociatedwithhighil6plasmalevelsandnormalizesearlyduringantimycobacterialtreatment AT adankwahernest impairedtcellresponsetophytohemagglutininphaintuberculosispatientsisassociatedwithhighil6plasmalevelsandnormalizesearlyduringantimycobacterialtreatment AT aniagyeiwilfred impairedtcellresponsetophytohemagglutininphaintuberculosispatientsisassociatedwithhighil6plasmalevelsandnormalizesearlyduringantimycobacterialtreatment AT acheampongisaac impairedtcellresponsetophytohemagglutininphaintuberculosispatientsisassociatedwithhighil6plasmalevelsandnormalizesearlyduringantimycobacterialtreatment AT minadzidifery impairedtcellresponsetophytohemagglutininphaintuberculosispatientsisassociatedwithhighil6plasmalevelsandnormalizesearlyduringantimycobacterialtreatment AT yeboahaugustine impairedtcellresponsetophytohemagglutininphaintuberculosispatientsisassociatedwithhighil6plasmalevelsandnormalizesearlyduringantimycobacterialtreatment AT arthurjosephf impairedtcellresponsetophytohemagglutininphaintuberculosispatientsisassociatedwithhighil6plasmalevelsandnormalizesearlyduringantimycobacterialtreatment AT lampteymillicent impairedtcellresponsetophytohemagglutininphaintuberculosispatientsisassociatedwithhighil6plasmalevelsandnormalizesearlyduringantimycobacterialtreatment AT abassmohammedk impairedtcellresponsetophytohemagglutininphaintuberculosispatientsisassociatedwithhighil6plasmalevelsandnormalizesearlyduringantimycobacterialtreatment AT kumbelfrancis impairedtcellresponsetophytohemagglutininphaintuberculosispatientsisassociatedwithhighil6plasmalevelsandnormalizesearlyduringantimycobacterialtreatment AT oseiyeboahfrancis impairedtcellresponsetophytohemagglutininphaintuberculosispatientsisassociatedwithhighil6plasmalevelsandnormalizesearlyduringantimycobacterialtreatment AT gawusuamidu impairedtcellresponsetophytohemagglutininphaintuberculosispatientsisassociatedwithhighil6plasmalevelsandnormalizesearlyduringantimycobacterialtreatment AT debrahlindabatsa impairedtcellresponsetophytohemagglutininphaintuberculosispatientsisassociatedwithhighil6plasmalevelsandnormalizesearlyduringantimycobacterialtreatment AT owusudorcaso impairedtcellresponsetophytohemagglutininphaintuberculosispatientsisassociatedwithhighil6plasmalevelsandnormalizesearlyduringantimycobacterialtreatment AT debrahalexander impairedtcellresponsetophytohemagglutininphaintuberculosispatientsisassociatedwithhighil6plasmalevelsandnormalizesearlyduringantimycobacterialtreatment AT mayatepekertan impairedtcellresponsetophytohemagglutininphaintuberculosispatientsisassociatedwithhighil6plasmalevelsandnormalizesearlyduringantimycobacterialtreatment AT seyfarthjulia impairedtcellresponsetophytohemagglutininphaintuberculosispatientsisassociatedwithhighil6plasmalevelsandnormalizesearlyduringantimycobacterialtreatment AT phillipsrichardo impairedtcellresponsetophytohemagglutininphaintuberculosispatientsisassociatedwithhighil6plasmalevelsandnormalizesearlyduringantimycobacterialtreatment AT jacobsenmarc impairedtcellresponsetophytohemagglutininphaintuberculosispatientsisassociatedwithhighil6plasmalevelsandnormalizesearlyduringantimycobacterialtreatment |